全大腸炎の英語

腸疾患の治療に有用な、さらに詳しくは、炎症性腸疾患（クローン病、潰瘍性大腸炎）および過敏性腸症候群の治療に有用であり、かつ、中枢神経系に対する作用の少ない安全性の高い薬剤を提供すること。例文帳に追加

To provide an agent useful for treatment of intestinal diseases, further particularly useful for treatment of inflammatory intestinal diseases (e.g. Crohn's disease and ulcerative colitis) and irritable bowel syndrome and having little action on central nervous system and high safety. - 特許庁

プロポリス又はその抽出物を含有する一酸化窒素合成酵素阻害剤、敗血症、エンドトキシンショック、心不全、ショック、低血圧、リウマチ性炎症、慢性関節リウマチ、変形性関節炎、潰瘍性大腸炎、ストレス性胃潰瘍、クローン病、自己免疫疾患、臓器移植後の組織障害若しくは拒絶反応等の治療剤、これらを含有する経口用組成物、食品、医薬。例文帳に追加

Propolis or its extract is used as a component of an NO synthetase inhibitor, an agent for the treatment of sepsis, endotoxin shock, cardiac failure, shock, hypotension, rheumatic inflammation, rheumatoid arthritis, arthritis deformans, ulcerous colitis, stress-related gastric ulcer, clone diseases, autoimmune diseases and tissue damages or rejection reactions after organ transplantation, and oral administration compositions, food products and pharmaceuticals containing the agent are also disclosed. - 特許庁

酸化型補酵素Ｑおよび還元型補酵素Ｑを併用することにより、または酸化型補酵素Ｑまたは還元型補酵素Ｑのいずれか一方を用いることにより、潰瘍性大腸炎および／又はクローン病に対して安全で有効性の高い治療剤を提供することができる。例文帳に追加

This safe treating agent against the ulcerative colitis and/or Crohn's disease, having the potent effectiveness is provided by using an oxidized type coenzyme Q and a reduced type coenzyme Q jointly, or either one of the oxidized type coenzyme Q or reduced type coenzyme Q. - 特許庁

アレルギー性疾患（アレルギー性鼻炎、アレルギー性結膜炎、アトピー性皮膚炎、気管支喘息、食物アレルギー等）、全身性肥満細胞症、全身性肥満細胞活性化障害、アナフィラキシーショック、気道収縮、蕁麻疹、湿疹、痒みを伴う疾患、炎症、慢性閉塞性肺疾患、虚血再灌流障害、脳血管障害、慢性関節リウマチ、胸膜炎、潰瘍性大腸炎等の疾患の予防および／または治療に有用な化合物の提供。例文帳に追加

To provide compounds useful for prevention and/or treatment of diseases such as allergic diseases (such as allergic rhinitis, allergic conjunctivitis, atopic dermatitis, bronchial asthma and food allergy), systemic mast cell disease, systemic mast cell activation failure, anaphylactic shock, respiratory tract contraction, urticaria, eczema, diseases associated with itch, inflammation, chronic obstructive pulmonary disease, ischemic reperfusion injury, cerebrovascular disorder, rheumatoid arthritis, pleuritis, ulcerative colitis. - 特許庁

ＮＦ−κＢの活性化に起因する疾患である、潰瘍性大腸炎、クローン病等の炎症性腸疾患や、全身性自己免疫疾患や臓器特異性免疫疾患等の自己免疫疾患の予防剤および／または治療剤として、システイン、グリシン、およびヒスチジンの少なくとも１つを有効成分として含有する医薬品、食品、飼料を提供する。例文帳に追加

The pharmaceuticals, foods and fodder comprising as an effective ingredient at least one from among cysteine, glycine and histidine are provided as a prophylactic agent and/or a therapeutic agent for inflammatory bowel diseases such as ulcerative colitis, and Crohn's disease, or autoimmune diseases such as a systemic autoimmune disease, and an organ-specific immune disease which are diseases caused by activation of NF-κB. - 特許庁

1：検査項目の例抗菌性物質等：抗生物質、合成抗菌剤、ホルモン剤等残留農薬：有機リン系、有機塩素系、カーバメイト系、ピレスロイド系等添加物：保存料、着色料、甘味料、酸化防止剤、防ばい剤等成分規格等：成分規格で定められている項目（細菌数、大腸菌群、腸炎ビブリオ、放射性物質等）、病原微生物（腸管出血性大腸菌Ｏ２６，Ｏ１０４、Ｏ１１１及びＯ１５７、リステリア菌等）、貝毒（下痢性貝毒、麻痺性貝毒）等カビ毒：アフラトキシン、デオキシニバレノール、パツリン等遺伝子組換え食品：安全性未審査遺伝子組換え食品等放射線照射：放射線照射の有無例文帳に追加

1: Examples of inspection items Antibacterial substances: antibiotics, synthetic antibacterial agents, hormone preparations, and others Residual agricultural chemicals: organophosphorus, organochlorines, carbamates, pyrethroids, and others Additives: preservatives, food coloring, sweeteners, antioxidants, antimold agents, and others Standards for constituents: items defined in the standards for constituents (such as the number of bacteria, coliform bacteria, Vibrio parahaemolyticus, and radioactive materials) pathogenic microorganisms (such as enterohemorrhagic Escherichia coli O26,O104,O111 and O157, and Listeria monocytogenes), shellfish poisons (diarrheic shellfish poisons, paralytic shellfish poisons), and others Mycotoxins: aflatoxin, deoxynivalenol, patulin, and others GMOs: Geneticallymodified organisms whose safety has not yet been certified Radiation irradiation: existence of radiation irradiation - 厚生労働省